![Vincenza Nigro](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Vincenza Nigro
Corporate Officer/Principal bei
HANSA BIOPHARMA AB
Profil
Vincenza Nigro is currently the Vice President-Global Medical Affairs at Hansa Biopharma AB since 2018.
Prior to this, she was the Head-Medical Affairs at Veloxis Pharmaceuticals A. Nigro holds an MBA from the Massachusetts Institute of Technology and an undergraduate degree from Fairleigh Dickinson University.
Aktive Positionen von Vincenza Nigro
| Unternehmen | Position | Beginn |
|---|---|---|
| HANSA BIOPHARMA AB | Corporate Officer/Principal | 17.09.2018 |
Ehemalige bekannte Positionen von Vincenza Nigro
| Unternehmen | Position | Ende |
|---|---|---|
| VELOXIS PHARMACEUTICALS A/S | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Vincenza Nigro
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
36
Beziehungen ersten Grades
4
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
Veloxis Pharmaceuticals A/S
 Veloxis Pharmaceuticals A/S Pharmaceuticals: MajorHealth Technology Develops and commercializes medicines for the prevention of organ rejection in kidney transplant patients | Health Technology |
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
Fairleigh Dickinson University
 Fairleigh Dickinson University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Hansa Biopharma AB
 Hansa Biopharma AB Pharmaceuticals: MajorHealth Technology Develops therapies and medicines for the treatment of immunomodulatory | Health Technology |
